Primary angiitis of central nervous system - A challenging diagnosis
Copyright © 2022 Elsevier B.V. All rights reserved..
Primary angiitis of the central nervous system is a rare disease characterized by vasculitis of the central nervous system without any systemic involvement. This review aims to provide an insight into the existing stagnancies in the diagnostic approach and management of this disease. The clinical presentation is typically nonspecific, ranging from headaches, altered sensorium, and seizures to recurrent ischemic strokes. The definitive diagnosis can only be ascertained by histopathological studies of tissue obtained from a brain biopsy. While angiography can provide clues to diagnosis, it has often been normal, even in biopsy-proven cases. Primary angiitis of the central nervous system continues to be a diagnostic challenge as little progress has been made over the years in the diagnosis and management strategies. Considering the vast list of mimickers of primary angiitis of the central nervous system and the existence of a significant proportion of imaging-negative and biopsy-negative cases, it becomes imperative to devise universally accepted diagnostic criteria for this disease. Steroids in combination with cyclophosphamide are the agents used to achieve remission. Rituximab can be an alternative. The treatment-related toxicity of cyclophosphamide warrants larger trials for alternative drugs to be studied.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:366 |
---|---|
Enthalten in: |
Journal of neuroimmunology - 366(2022) vom: 15. Mai, Seite 577844 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Paul, Shabeer Ahmad [VerfasserIn] |
---|
Links: |
---|
Themen: |
8N3DW7272P |
---|
Anmerkungen: |
Date Completed 11.04.2022 Date Revised 22.05.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.jneuroim.2022.577844 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM338297103 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM338297103 | ||
003 | DE-627 | ||
005 | 20231226000344.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jneuroim.2022.577844 |2 doi | |
028 | 5 | 2 | |a pubmed24n1127.xml |
035 | |a (DE-627)NLM338297103 | ||
035 | |a (NLM)35299076 | ||
035 | |a (PII)S0165-5728(22)00039-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Paul, Shabeer Ahmad |e verfasserin |4 aut | |
245 | 1 | 0 | |a Primary angiitis of central nervous system - A challenging diagnosis |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.04.2022 | ||
500 | |a Date Revised 22.05.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 Elsevier B.V. All rights reserved. | ||
520 | |a Primary angiitis of the central nervous system is a rare disease characterized by vasculitis of the central nervous system without any systemic involvement. This review aims to provide an insight into the existing stagnancies in the diagnostic approach and management of this disease. The clinical presentation is typically nonspecific, ranging from headaches, altered sensorium, and seizures to recurrent ischemic strokes. The definitive diagnosis can only be ascertained by histopathological studies of tissue obtained from a brain biopsy. While angiography can provide clues to diagnosis, it has often been normal, even in biopsy-proven cases. Primary angiitis of the central nervous system continues to be a diagnostic challenge as little progress has been made over the years in the diagnosis and management strategies. Considering the vast list of mimickers of primary angiitis of the central nervous system and the existence of a significant proportion of imaging-negative and biopsy-negative cases, it becomes imperative to devise universally accepted diagnostic criteria for this disease. Steroids in combination with cyclophosphamide are the agents used to achieve remission. Rituximab can be an alternative. The treatment-related toxicity of cyclophosphamide warrants larger trials for alternative drugs to be studied | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Central nervous system | |
650 | 4 | |a Primary angiitis of the central nervous system | |
650 | 4 | |a Review | |
650 | 4 | |a Vasculitis | |
650 | 7 | |a Cyclophosphamide |2 NLM | |
650 | 7 | |a 8N3DW7272P |2 NLM | |
700 | 1 | |a Roy, Devlina |e verfasserin |4 aut | |
700 | 1 | |a Mondal, Gouranga Prasad |e verfasserin |4 aut | |
700 | 1 | |a Bhattacharyya, Ramesh |e verfasserin |4 aut | |
700 | 1 | |a Ghosh, Kartik Chandra |e verfasserin |4 aut | |
700 | 1 | |a Das, Sarbajit |e verfasserin |4 aut | |
700 | 1 | |a Krishna, Hema |e verfasserin |4 aut | |
700 | 1 | |a Patra, Chandrakanta |e verfasserin |4 aut | |
700 | 1 | |a Kiran, Jyoti |e verfasserin |4 aut | |
700 | 1 | |a Benito-León, Julián |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of neuroimmunology |d 1985 |g 366(2022) vom: 15. Mai, Seite 577844 |w (DE-627)NLM012614181 |x 1872-8421 |7 nnns |
773 | 1 | 8 | |g volume:366 |g year:2022 |g day:15 |g month:05 |g pages:577844 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jneuroim.2022.577844 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 366 |j 2022 |b 15 |c 05 |h 577844 |